Bruker (BRKR) Revenue Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | 8.89 Bn | 8.77 Bn | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.22% |
| Dec 31, 2025 | -42.56% |
| Sep 30, 2025 | 10.97% |
| Jun 30, 2025 | 13.43% |
| Mar 31, 2025 | 13.58% |
| Dec 31, 2024 | 10.30% |
| Sep 30, 2024 | 10.65% |
| Jun 30, 2024 | 10.31% |
| Mar 31, 2024 | 9.36% |
| Dec 31, 2023 | 9.07% |
| Sep 30, 2023 | 9.75% |
| Jun 30, 2023 | 8.97% |
| Mar 31, 2023 | 9.68% |
| Dec 31, 2022 | 5.95% |
| Sep 30, 2022 | 7.96% |
| Jun 30, 2022 | 7.24% |
| Mar 31, 2022 | 9.10% |
| Dec 31, 2021 | 7.76% |
| Sep 30, 2021 | 9.10% |
| Jun 30, 2021 | 8.96% |
| Mar 31, 2021 | 8.12% |
| Dec 31, 2020 | 5.58% |
| Sep 30, 2020 | 5.24% |
| Jun 30, 2020 | 1.40% |
| Mar 31, 2020 | 3.70% |
| Dec 31, 2019 | 3.38% |
| Sep 30, 2019 | 4.42% |
| Jun 30, 2019 | 1.39% |
| Mar 31, 2019 | 1.72% |
| Dec 31, 2018 | 0.05% |
| Sep 30, 2018 | 1.23% |
| Jun 30, 2018 | -0.50% |
| Mar 31, 2018 | 1.88% |
| Dec 31, 2017 | 0.51% |
| Sep 30, 2017 | -0.55% |
| Jun 30, 2017 | -0.28% |
| Mar 31, 2017 | -1.04% |
| Dec 31, 2016 | -0.20% |
| Sep 30, 2016 | -1.20% |
| Jun 30, 2016 | -1.52% |
| Mar 31, 2016 | 1.01% |
| Dec 31, 2015 | 2.82% |
| Sep 30, 2015 | 5.01% |
| Jun 30, 2015 | 5.65% |
| Mar 31, 2015 | 4.95% |